NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity Yazar: Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt

Tam Metin Erişim

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer Yazar: Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt

Tam Metin Erişim

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E Yazar: Jack G. Fisher, Christopher J. Walker, Amber DP. Doyle, Peter WM. Johnson, Francesco Forconi, Mark S. Cragg, Yosef Landesman, Salim. I. Khakoo, Matthew D. Blunt

Tam Metin Erişim

Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis Yazar: Theresa J. Hydes, Matthew D. Blunt, Jennifer Naftel, Andres F. Vallejo, Grégory Seumois, Alice Wang, Pandurangan Vijayanand, Pandurangan Vijayanand, Marta E. Polak, Salim I. Khakoo

Tam Metin Erişim

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors Yazar: Aymen Al-Shamkhani, Marta E Polak, Pauline Rettman, Matthew D Blunt, Rebecca J Fulton, Andres F Vallejo, Leidy Y Bastidas-Legarda, Laura España-Serrano, Christelle Retiere, Salim I Khakoo

Tam Metin Erişim

KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies Yazar: Lara V. Graham, Jack G. Fisher, Amber D. P. Doyle, Ben Sale, Luis Del Rio, Albert J. E. French, Neema P. Mayor, Neema P. Mayor, Thomas R. Turner, Thomas R. Turner, Steven G. E. Marsh, Steven G. E. Marsh, Mark S. Cragg, Mark S. Cragg, Francesco Forconi, Francesco Forconi, Salim I. Khakoo, Matthew D. Blunt

Tam Metin Erişim